1. Home
  2. XOMA vs MHN Comparison

XOMA vs MHN Comparison

Compare XOMA & MHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • MHN
  • Stock Information
  • Founded
  • XOMA 1981
  • MHN 1997
  • Country
  • XOMA United States
  • MHN United States
  • Employees
  • XOMA N/A
  • MHN N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • MHN Investment Bankers/Brokers/Service
  • Sector
  • XOMA Health Care
  • MHN Finance
  • Exchange
  • XOMA Nasdaq
  • MHN Nasdaq
  • Market Cap
  • XOMA 355.6M
  • MHN 334.2M
  • IPO Year
  • XOMA N/A
  • MHN N/A
  • Fundamental
  • Price
  • XOMA $30.21
  • MHN $10.60
  • Analyst Decision
  • XOMA Strong Buy
  • MHN
  • Analyst Count
  • XOMA 2
  • MHN 0
  • Target Price
  • XOMA $78.50
  • MHN N/A
  • AVG Volume (30 Days)
  • XOMA 30.4K
  • MHN 59.2K
  • Earning Date
  • XOMA 11-07-2024
  • MHN 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • MHN 4.17%
  • EPS Growth
  • XOMA N/A
  • MHN N/A
  • EPS
  • XOMA N/A
  • MHN N/A
  • Revenue
  • XOMA $21,606,000.00
  • MHN N/A
  • Revenue This Year
  • XOMA $488.61
  • MHN N/A
  • Revenue Next Year
  • XOMA $27.42
  • MHN N/A
  • P/E Ratio
  • XOMA N/A
  • MHN N/A
  • Revenue Growth
  • XOMA 389.82
  • MHN N/A
  • 52 Week Low
  • XOMA $14.33
  • MHN $8.69
  • 52 Week High
  • XOMA $33.78
  • MHN $10.81
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 52.03
  • MHN 39.63
  • Support Level
  • XOMA $29.09
  • MHN $10.69
  • Resistance Level
  • XOMA $32.50
  • MHN $10.79
  • Average True Range (ATR)
  • XOMA 1.87
  • MHN 0.10
  • MACD
  • XOMA -0.17
  • MHN 0.01
  • Stochastic Oscillator
  • XOMA 49.29
  • MHN 15.15

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About MHN Blackrock MuniHoldings New York Quality Fund Inc.

BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. is a closed-ended management investment company. The fund's investment objective is to provide shareholders with current income exempt from federal income tax and New York State and New York City personal income taxes.

Share on Social Networks: